Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $67.2600 (-2.8%) ($67.2000 - $69.2900) on Tue. Dec. 4, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.76% (three month average) | RSI | 68 | Latest Price | $67.2600(-2.8%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 0.4% a day on average for past five trading days. | Weekly Trend | BAX advances 2.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(57%) SPLV(53%) VYM(52%) XLP(52%) IVE(49%) | Factors Impacting BAX price | BAX will decline at least -0.88% in a week (0% probabilities). TLT(-20%) DIA(-13%) GDXJ(-11%) VIXM(-10%) VXX(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.88% (StdDev 1.76%) | Hourly BBV | 0 () | Intraday Trend | -2.7% | | | |
|
5 Day Moving Average | $68.27(-1.48%) | 10 Day Moving Average | $66.93(0.49%) | 20 Day Moving Average | $65.54(2.62%) | To recent high | -13.5% | To recent low | 9.3% | Market Cap | $34.315b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |